About
James E. Dillard III was named Executive Vice President and Chief Scientific Officer in January 2019. Mr. Dillard joined Perrigo from Altria Group, Inc., where he served as Senior Vice President, Research, Development and Sciences and Chief Innovation Officer. During his tenure with Altria Group, Mr. Dillard led the creation of the Regulatory Affairs function in 2009 and also served as Chief Innovation Officer for Altria Client Services and Senior Vice President of Research, Development & Regulatory Affairs, for Altria Group. He held science and technology leadership roles with U. S. Smokeless Tobacco Company (USSTC), an Altria Group Inc. operating company, from 2001 to 2009. Mr. Dillard worked for the U.S. Food and Drug Administration (FDA) between 1987 and 2001, as Director of the Division of Cardiovascular and Respiratory Devices, as well as in various leadership roles in the Center for Devices and Radiological Health and the Office of Device Evaluation.
Position in the VCSift Database
- • 1 investors hold the Senior Vice President, Regulatory Affairs role in VCSift. James E. Dillard is one of them.
- • 75 investors are based in Grand Rapids, Michigan, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Grand Rapids, US
Contact Information
Find more investors like James
Search Investors